Explore the FAQs (Frequently Asked Questions) regarding the 3rd Spatial Biology for Drug Development Summit:
What is the 3rd Spatial Biology for Drug Development Summit?
The 3rd Spatial Biology for Drug Development Summit is the leading industry meeting dedicated to applying spatial biology, spatial transcriptomics, spatial proteomics, and multi-omics integration to accelerate drug discovery, translational research, biomarker development, and clinical trials. This Summit unites large pharma, biotech, and academic leaders (for free!) to share case studies, tackle challenges in standardization, reproducibility, and data integration, and explore how spatial insights can drive more precise and effective therapeutics.
When & When?
October 22-23, 2025
Boston, MA
Where is the Venue?
Hotel Commonwealth
500 Commonwealth Avenue
Boston, MA 02215
United States
Why is Spatial Biology Important?
Spatial biology is important to unlock insights that are directly shaping the future of drug development.
From identifying new targets and mechanisms of action to refining patient stratification, biomarker strategies, and clinical trial endpoints, this technology is constantly referred to as ‘The Next NGS’. By providing spatially resolved context around cell–cell interactions, immune infiltration, and tissue heterogeneity, these technologies are driving smarter decisions across discovery, translational research, and clinical development.
It is vital to bring the spatial biology community together because no single organization can solve the challenges alone. Pharma, biotech, solution providers, and academia need to align on standards, data integration, and workflows that make spatial approaches reproducible, scalable, and ultimately clinically actionable. By convening the field, the summit creates a unique forum to share data, benchmark technologies, and build the collaborations required to accelerate the adoption of spatial biology in drug development and precision medicine.
Is it Free to Attend? Why?
Yes, the 3rd Spatial Biology for Drug Development Summit is *free to attend for biopharma professionals. We want to ensure strong representation from large pharma and innovative biotech using spatial biology, spatial transcriptomics, proteomics, and multi-omics technologies. This is not a free-to-attend event for solution providers, technology companies, or service organizations – their participation supports the Summit and enables us to keep access complimentary for the biopharma community.
By making the meeting learning-centred and removing financial barriers for drug developers, and leading academic experts, we maximize opportunities for knowledge exchange, networking, and collaboration. This creates the richest possible discussions to accelerate the adoption of spatial biology tools in drug discovery, clinical research, and biomarker development.
Who Can I Expect to Meet?
This meeting is the ultimate forum for networking and collaborating with Chiefs, Presidents, Directors, Leads, Scientists, and more, all focusing on: spatial biology, biomarker discovery, companion diagnostics, spatial omics, translational biology, NGS, Immunology, & more!
Simply get in touch today to request a blind copy of this year's attendees.
What Companies Usually Attends the Conference?
Pharma
Biotech
Academia/Researchers
Solution & Service Providers
What are the Key Agenda Topics?
The 3rd Spatial Biology for Drug Development Summit will cover the most pressing topics shaping how spatial technologies are applied across the entire drug discovery and development pipeline. Key themes include:
By focusing on these areas, the summit brings together pharma, biotech, and academic leaders to accelerate the use of spatial biology in precision medicine, biomarker strategy, and translational success.
Who are the Expert Speakers?
- Senior Vice President - Computational Science Discovery, Affinia Therapeutics
- Executive Director, Computational Imaging & Digital Biomarkers, Amgen
- Executive Director, Translational Immunology, Genentech
- Head, Next Generation Sequencing, Systems & Immunology Group, Pfizer
- Vice President of Biology, Pheon Therapeutics Ltd
- Director, Companion Diagnostics, Daiichi Sankyo
- Senior Director, Research Pathology, Gilead
- Senior Director, Data Science & Digital Health, Johnson & Johnson
- Director, Translational Medicine, AstraZeneca
- Senior Director, Pathologist Translational Medicine, AstraZeneca
- Executive Director, Clinical Diagnostics Laboratory, Eli Lilly
- Associate Director, Spatial Transcriptomics, Takeda
And so many more…
Is there Dedicated Networking Time?
Yes, there are dedicated networking slots across the 2-day conference. There is time set aside throughout the agenda for you to meet people properly, from speed networking and coffee breaks to roundtable discussions and the poster session. Whether you’re after quick introductions or longer conversations, there’s plenty of space to connect.
Any further questions? Don’t hesitate to reach out to a member of the team:
Partnership Opportunities
Ezgi Vedat-Irikzade
Partnerships Director
Speaking Opportunities
Nick Lewis
Program Director
Media & Press Opportunities
Isabel Weir
Senior Marketing Executive
Attendance Opportunities
Rushil Boorgula
Delegate Audience Manager